Alka-Seltzer Plus Cold Formula Sparkling Original Effervescent Tablets (aspirin / chlorpheniramine / phenylephrine) Drug Interactions
A total of 1247 drugs (6730 brand and generic names) are known to interact with Alka-Seltzer Plus Cold Formula Sparkling Original Effervescent Tablets (aspirin / chlorpheniramine / phenylephrine).
- 283 major drug interactions (1935 brand and generic names)
- 926 moderate drug interactions (4615 brand and generic names)
- 38 minor drug interactions (180 brand and generic names)
Check for interactions with Alka-Seltzer Plus Cold Formula Sparkling Original Effervescent Tablets (aspirin / chlorpheniramine / phenylephrine)
Common medications checked in combination with Alka-Seltzer Plus Cold Formula Sparkling Original Effervescent Tablets (aspirin / chlorpheniramine / phenylephrine)
- acetaminophen
- acetaminophen / codeine
- Adderall (amphetamine / dextroamphetamine)
- Alka-Seltzer Plus Cold & Cough Formula Liquid Gels (acetaminophen / chlorpheniramine / dextromethorphan / phenylephrine)
- citalopram
- cyclobenzaprine
- ibuprofen
- lisinopril
- meloxicam
- metformin
- multivitamin
- naproxen
- oxycodone
- prednisone
- ProAir HFA (albuterol)
- pseudoephedrine
- tramadol
- Ultram (tramadol)
- venlafaxine
- Vitamin D3 (cholecalciferol)
Alka-Seltzer Plus Cold Formula Sparkling Original Effervescent Tablets (aspirin / chlorpheniramine / phenylephrine) alcohol/food Interactions
There are 2 alcohol/food interactions with Alka-Seltzer Plus Cold Formula Sparkling Original Effervescent Tablets (aspirin / chlorpheniramine / phenylephrine)
Alka-Seltzer Plus Cold Formula Sparkling Original Effervescent Tablets (aspirin / chlorpheniramine / phenylephrine) disease Interactions
There are 17 disease interactions with Alka-Seltzer Plus Cold Formula Sparkling Original Effervescent Tablets (aspirin / chlorpheniramine / phenylephrine) which include:
- Anticholinergic Effects
- Coagulation
- Asthma
- Gi Toxicity
- Renal Dysfunction
- Reye's Syndrome
- Cardiovascular Disease
- Asthma/Copd
- Cardiovascular
- Renal/Liver Disease
- Anemia
- Dialysis
- G-6-Pd Deficiency
- Hepatotoxicity
- Bph
- Diabetes
- Glaucoma
See also...
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No information available. |
Do not stop taking any medications without consulting your healthcare provider.
Disclaimer: Every effort has been made to ensure that the information provided by Multum is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. Multum's information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill, knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2017 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
